Literature DB >> 24657243

Glucocorticoid receptor function is decreased in neutrophils during endotoxic shock.

Maria Bergquist1, Pernilla Jirholt2, Merja Nurkkala2, Christian Rylander3, Göran Hedenstierna4, Catharina Lindholm2.   

Abstract

OBJECTIVES: It remains unclear whether glucocorticoid treatment can improve the outcome of sepsis. The aim of the present study was to investigate if glucocorticoid receptor (GR) expression and function is impaired in lipopolysaccharide (LPS) induced shock, and whether the time point for start of glucocorticoid treatment affects the outcome.
METHODS: Male C57BL/6J mice were administered LPS i.p. and GR expression and binding ability in blood and spleen leukocytes were analysed by flow cytometry. GR translocation was analysed using Image Stream technique. The effect of dexamethasone treatment started 2 h before or 2, 12 or 36 h after LPS administration on survival was studied.
RESULTS: Despite increased GR expression in neutrophils after LPS administration, the GR binding capacity was reduced. In addition, GR translocation was decreased in neutrophils and T lymphocytes from endotoxic mice at 12 h compared to control animals. Dexamethasone treatment improved survival only when started early (2 h) after LPS administration.
CONCLUSION: The decreased glucocorticoid responsiveness displayed by neutrophils, in combination with their increased numbers, may explain why survival is increased only when dexamethasone treatment is given early during LPS induced shock.
Copyright © 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dexamethasone; Endotoxin; Glucocorticoid receptor; Lipopolysaccharide; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 24657243     DOI: 10.1016/j.jinf.2014.03.011

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

Review 1.  Corticosteroids in the adjunctive therapy of community-acquired pneumonia: an appraisal of recent meta-analyses of clinical trials.

Authors:  Charles Feldman; Ronald Anderson
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

Review 2.  CIRMI-a new term for a concept worthy of further exploration: a narrative review.

Authors:  Gladness Dakalo Nethathe; Jeffrey Lipman; Ronald Anderson; Charles Feldman
Journal:  Ann Transl Med       Date:  2022-06

Review 3.  Adrenal function and dysfunction in critically ill patients.

Authors:  Arno Téblick; Bram Peeters; Lies Langouche; Greet Van den Berghe
Journal:  Nat Rev Endocrinol       Date:  2019-07       Impact factor: 43.330

4.  Effect of low-dose corticosterone pretreatment on the production of inflammatory mediators in super-low-dose LPS-primed immune cells.

Authors:  Byeong Suk Chae
Journal:  Toxicol Res       Date:  2020-08-12

Review 5.  Macrophage inflammatory protein-2 as mediator of inflammation in acute liver injury.

Authors:  Chao-Chao Qin; Yan-Ning Liu; Ying Hu; Ying Yang; Zhi Chen
Journal:  World J Gastroenterol       Date:  2017-05-07       Impact factor: 5.742

6.  Increased glucocorticoid receptor expression in sepsis is related to heat shock proteins, cytokines, and cortisol and is associated with increased mortality.

Authors:  Konstantinos Vardas; Stavroula Ilia; Amalia Sertedaki; Evangelia Charmandari; Efrossini Briassouli; Dimitris Goukos; Kleovoulos Apostolou; Katerina Psarra; Efthimia Botoula; Stylianos Tsagarakis; Eleni Magira; Christina Routsi; Constantine A Stratakis; Serafim Nanas; George Briassoulis
Journal:  Intensive Care Med Exp       Date:  2017-02-21

Review 7.  Immune Effects of Corticosteroids in Sepsis.

Authors:  Nicholas Heming; Sivanthiny Sivanandamoorthy; Paris Meng; Rania Bounab; Djillali Annane
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

8.  Impairment of neutrophilic glucocorticoid receptor function in patients treated with steroids for septic shock.

Authors:  Maria Bergquist; Catharina Lindholm; Morten Strinnholm; Göran Hedenstierna; Christian Rylander
Journal:  Intensive Care Med Exp       Date:  2015-07-28

9.  A novel nitro-dexamethasone inhibits agr system activity and improves therapeutic effects in MRSA sepsis models without antibiotics.

Authors:  Yun Yang; Haibo Li; Hongwu Sun; Li Gong; Ling Guo; Yun Shi; Changzhi Cai; Hao Gu; Zhen Song; Liuyang Yang; Yanan Tong; Chao Wei; Quanming Zou; Hao Zeng
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

Review 10.  Glucocorticoids in Sepsis: To Be or Not to Be.

Authors:  Jolien Vandewalle; Claude Libert
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.